Vanguard Group
MEDS

Vanguard Group’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Vanguard Group’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$340K Buy
17,022
+2,237
+15% +$65.6K ﹤0.01% 4018
2025
Q3 		$656K Buy
+14,785
New +$780K ﹤0.01% 3889

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Vanguard Group's MEDS Position: Q4 2025 in Review

Vanguard Group increased its DataMeds AI, Inc. Common Stock (MEDS) stake by 15% in Q4 2025, buying an estimated $65.6K and bringing the position to 17,022 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #4018.

Vanguard Group first reported a position in MEDS in Q3 2025 and has held it in 2 quarters since. The position peaked at $656K in Q3 2025. 19 funds tracked by Wall St. Rank hold MEDS as of Q4 2025.

  • Vanguard Group held 17,022 shares of DataMeds AI, Inc. Common Stock worth $340K as of Q4 2025.
  • Vanguard Group bought 2,237 DataMeds AI, Inc. Common Stock shares in Q4 2025, an estimated $65.6K.
  • DataMeds AI, Inc. Common Stock made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4018 holding.
  • Vanguard Group first reported a position in DataMeds AI, Inc. Common Stock in Q3 2025 and has held it in 2 quarters since.
  • Vanguard Group's DataMeds AI, Inc. Common Stock position peaked at $656K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.